Cranial Nerve Stimulator Relieves Abdominal Pain
|
By HospiMedica International staff writers Posted on 17 Jun 2019 |

A new percutaneous device is designed to stimulate cranial nerves to temper IBS pain (Photo courtesy of IHS).
A new non-surgical device sends gentle electrical impulses into cranial nerve bundles located around the ear to reduce the abdominal pain associated with irritable bowel syndrome (IBS).
The Innovative Health Solutions (IHS; Versailles, IN, USA) IB-Stim is a percutaneous electrical nerve field stimulator (PENFS) system intended for patients 11-18 years of age with functional abdominal pain related with IBS. The device is applied behind the ear, with small electrodes placed to stimulate branches of cranial nerves V, VII, IX and X, and the occipital nerves; the precise nerve locations are identified by transillumination. While the exact mechanism of action is unclear, it is hypothesized the system works by controlling activity of pain areas in the central nervous system (CNS), particularly the amygdala and spinal cord.
The prescription-only device contains a battery-powered chip that emits low-frequency electrical pulses to stimulate the cranial nerves branches continuously for five days (120 hours) per week, at which time it is replaced. Patients can use the device for up to three consecutive weeks, in conjunction with other modalities for treatment of chronic abdominal pain, including medication. IB-Stim is contraindicated for patients with hemophilia, patients with cardiac pacemakers, or those diagnosed with psoriasis vulgaris, a condition in which skin cells build up and form scales and itchy, dry patches.
“This device offers a safe option for treatment of adolescents experiencing pain from IBS through the use of mild nerve stimulation,” said Carlos Peña, PhD, director of the Office of Neurological and Physical Medicine Devices at the FDA Center for Devices and Radiological Health (CDRH). “Today’s action reflects our ongoing commitment to advancing the development of pediatric medical devices so that children and adolescents have access to safe and effective medical devices that meet their needs.”
IBS is a diagnosis of exclusion. It is a functional bowel disorder characterized by chronic abdominal pain, discomfort, bloating, and alteration of bowel habits in the absence of any detectable organic cause. Sometimes, the painful symptoms are relieved by bowel movements. Diarrhea or constipation may predominate, or they may alternate (classified as IBS-D, IBS-C or IBS-A, respectively). IBS may begin after an infection (post-infectious, IBS-PI), a stressful life event, or onset of maturity without any other medical indicators.
Related Links:
Innovative Health Solutions
The Innovative Health Solutions (IHS; Versailles, IN, USA) IB-Stim is a percutaneous electrical nerve field stimulator (PENFS) system intended for patients 11-18 years of age with functional abdominal pain related with IBS. The device is applied behind the ear, with small electrodes placed to stimulate branches of cranial nerves V, VII, IX and X, and the occipital nerves; the precise nerve locations are identified by transillumination. While the exact mechanism of action is unclear, it is hypothesized the system works by controlling activity of pain areas in the central nervous system (CNS), particularly the amygdala and spinal cord.
The prescription-only device contains a battery-powered chip that emits low-frequency electrical pulses to stimulate the cranial nerves branches continuously for five days (120 hours) per week, at which time it is replaced. Patients can use the device for up to three consecutive weeks, in conjunction with other modalities for treatment of chronic abdominal pain, including medication. IB-Stim is contraindicated for patients with hemophilia, patients with cardiac pacemakers, or those diagnosed with psoriasis vulgaris, a condition in which skin cells build up and form scales and itchy, dry patches.
“This device offers a safe option for treatment of adolescents experiencing pain from IBS through the use of mild nerve stimulation,” said Carlos Peña, PhD, director of the Office of Neurological and Physical Medicine Devices at the FDA Center for Devices and Radiological Health (CDRH). “Today’s action reflects our ongoing commitment to advancing the development of pediatric medical devices so that children and adolescents have access to safe and effective medical devices that meet their needs.”
IBS is a diagnosis of exclusion. It is a functional bowel disorder characterized by chronic abdominal pain, discomfort, bloating, and alteration of bowel habits in the absence of any detectable organic cause. Sometimes, the painful symptoms are relieved by bowel movements. Diarrhea or constipation may predominate, or they may alternate (classified as IBS-D, IBS-C or IBS-A, respectively). IBS may begin after an infection (post-infectious, IBS-PI), a stressful life event, or onset of maturity without any other medical indicators.
Related Links:
Innovative Health Solutions
Latest Critical Care News
- Noninvasive Monitoring Device Enables Earlier Intervention in Heart Failure
- Automated IV Labeling Solution Improves Infusion Safety and Efficiency
- First-Of-Its-Kind AI Tool Detects Pulmonary Hypertension from Standard ECGs
- 4D Digital Twin Heart Model Improves CRT Outcomes
- AI Turns Glucose Data Into Actionable Insights for Diabetes Care
- Microscale Wireless Implant Tracks Brain Activity Over Time
- Smart Mask Delivers Continuous, Battery-Free Breath Monitoring
- Routine Blood Pressure Readings May Identify Risk of Future Cognitive Decline
- CGM-Based Algorithm Enhances Insulin Dose Adjustment in Type 2 Diabetes
- Fish Scale–Based Implants Offer New Approach to Corneal Repair
- Dual-Function Wound Patch Combines Infection Sensing and Treatment
- Smartwatch Signals and Blood Tests Team Up for Early Warning on Insulin Resistance
- Smart Fabric Technology Aims to Prevent Pressure Injuries in Hospital Care
- Standardized Treatment Algorithm Improves Blood Pressure Control
- Combined Infection Control Strategy Limits Drug-Resistant Outbreak in NICU
- AI Helps Predict Which Heart-Failure Patients Will Worsen Within a Year
Channels
Artificial Intelligence
view channelAI Analysis of Pericardial Fat Refines Long-Term Heart Disease Risk
Accurately identifying long-term cardiovascular disease risk in asymptomatic adults remains challenging for clinicians. Missed or underestimated risk delays preventive therapy and increases the chance... Read more
Machine Learning Approach Enhances Liver Cancer Risk Stratification
Hepatocellular carcinoma, the most common form of primary liver cancer, is often detected late despite targeted surveillance programs. Current screening guidelines emphasize patients with known cirrhosis,... Read moreSurgical Techniques
view channel
Ultrasound Technology Aims to Replace Invasive BPH Procedures
Benign prostatic hyperplasia (BPH) is a frequent cause of lower urinary tract symptoms in aging men and often requires invasive procedures or prolonged recovery. With prevalence expected to rise as populations... Read more
Continuous Monitoring with Wearables Enhances Postoperative Patient Safety
Postoperative hypoxemia on general surgical wards is common and often missed by intermittent vital sign checks. Undetected low oxygen levels can delay recovery and raise the risk of complications that... Read morePatient Care
view channel
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care
More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read moreHealth IT
view channel
EMR-Based Tool Predicts Graft Failure After Kidney Transplant
Kidney transplantation offers patients with end-stage kidney disease longer survival and better quality of life than dialysis, yet graft failure remains a major challenge. Although a successful transplant... Read more
Printable Molecule-Selective Nanoparticles Enable Mass Production of Wearable Biosensors
The future of medicine is likely to focus on the personalization of healthcare—understanding exactly what an individual requires and delivering the appropriate combination of nutrients, metabolites, and... Read moreBusiness
view channel







